Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms

Journal of Virology

Volumn 84, Issue 24, 2010, Pages 12646-12657

  Weidner, Jessica M ^a   Jiang, Dong ^a   Pan, Xiao Ben ^a   Chang, Jinhong ^a   Block, Timothy M ^a,b   Guo, Ju Tao ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HEPATITIS B FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; INTERFERON INDUCED CELL MEMBRANE PROTEIN IFITM3; INTERFERON INDUCED CELL MEMBRANE PROTEIN TETHERIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOCYTOSIS; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION TERMINATION; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS GENOME; VIRUS INHIBITION; VIRUS PARTICLE;

ANTIGENS, CD; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; ENDOCYTOSIS; GENOME, VIRAL; GPI-LINKED PROTEINS; HUMANS; MEMBRANE PROTEINS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE; RHABDOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 78649404289     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01328-10     Document Type: Article

References (50)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Andreu, P., S. Colnot, C. Godard, P. Laurent-Puig, D. Lamarque, A. Kahn, C. Perret, and B. Romagnolo. 2006. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 66:1949-1955.
3. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
4. Brass, A. L., I. C. Huang, Y. Benita, S. P. John, M. N. Krishnan, E. M. Feeley, B. J. Ryan, J. L. Weyer, L. van der Weyden, E. Fikrig, D. J. Adams, R. J. Xavier, M. Farzan, and S. J. Elledge. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
5. Brem, R., K. Oraszlan-Szovik, S. Foser, B. Bohrmann, and U. Certa. 2003. Inhibition of proliferation by 1-8U in interferon-alpha-responsive and non-responsive cell lines. Cell. Mol. Life Sci. 60:1235-1248.
6. Brinton, M. A. 2002. The molecular biology of West Nile virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 56:371-402.
7. Carey, B. L., M. Ahmed, S. Puckett, and D. S. Lyles. 2008. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus. J. Virol. 82:12104-12115.
8. Clyde, K., J. L. Kyle, and E. Harris. 2006. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol. 80:11418-11431. (Pubitemid 44788858)
9. Cureton, D. K., R. H. Massol, S. Saffarian, T. L. Kirchhausen, and S. P. Whelan. 2009. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog. 5:e1000394.
10. Deblandre, G. A., O. P. Marinx, S. S. Evans, S. Majjaj, O. Leo, D. Caput, G. A. Huez, and M. G. Wathelet. 1995. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 270:23860-23866.
11. Durbin, R. K., S. E. Mertz, A. E. Koromilas, and J. E. Durbin. 2002. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol. 15:41-51.
12. Espert, L., G. Degols, C. Gongora, D. Blondel, B. R. Williams, R. H. Silverman, and N. Mechti. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278:16151-16158.
13. Fitzpatrick, K., M. Skasko, T. J. Deerinck, J. Crum, M. H. Ellisman, and J. Guatelli. 2010. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog. 6:e1000701.
14. Guo, J. T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
15. Guo, J. T., J. Hayashi, and C. Seeger. 2005. West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 79:1343-1350. (Pubitemid 40459081)
16. Habjan, M., N. Penski, V. Wagner, M. Spiegel, A. K. Overby, G. Kochs, J. T. Huiskonen, and F. Weber. 2009. Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 385:400-408.
17. Hammonds, J., J. J. Wang, H. Yi, and P. Spearman. 2010. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog. 6:e1000749.
18. Hayashi, J., R. Stoyanova, and C. Seeger. 2005. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 335:264-275. (Pubitemid 40544915)
19. Huang, H., F. Sun, D. M. Owen, W. Li, Y. Chen, M. Gale, Jr., and J. Ye. 2007. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 104:5848-5853.
20. Jiang, D., H. Guo, C. Xu, J. Chang, B. Gu, L. Wang, T. M. Block, and J. T. Guo. 2008. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 82:1665-1678.
21. Jiang, D., J. M. Weidner, M. Qing, X. B. Pan, H. Guo, C. Xu, X. Zhang, A. Birk, J. Chang, P. Y. Shi, T. M. Block, and J. T. Guo. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84:8332-8341.
22. Johannsdottir, H. K., R. Mancini, J. Kartenbeck, L. Amato, and A. Helenius. 2009. Host cell factors and functions involved in vesicular stomatitis virus entry. J. Virol. 83:440-453.
23. Jouvenet, N., S. J. Neil, M. Zhadina, T. Zang, Z. Kratovac, Y. Lee, M. McNatt, T. Hatziioannou, and P. D. Bieniasz. 2009. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83:1837-1844.
24. Kaletsky, R. L., J. R. Francica, C. Agrawal-Gamse, and P. Bates. 2009. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 106:2886-2891.
25. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145. (Pubitemid 46775751)
26. Lange, U. C., D. J. Adams, C. Lee, S. Barton, R. Schneider, A. Bradley, and M. A. Surani. 2008. Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol. Cell. Biol. 28:4688-4696.
27. Lewin, A. R., L. E. Reid, M. McMahon, G. R. Stark, and I. M. Kerr. 1991. Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199:417-423.
28. Lewis, M. J., and H. R. Pelham. 1992. Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell 68:353-364.
29. Miyagi, E., A. J. Andrew, S. Kao, and K. Strebel. 2009. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U. S. A. 106:2868-2873.
30. Miyanari, Y., K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
31. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
32. Perez-Caballero, D., T. Zang, A. Ebrahimi, M. W. McNatt, D. A. Gregory, M. C. Johnson, and P. D. Bieniasz. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499-511.
33. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27:370-383.
34. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5:375-386.
35. Rose, J. K., and M. A. Whitt. 2001. Rhabdoviridae: the viruses and their replication, p. 1221-1277. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
36. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
37. Sakuma, T., T. Noda, S. Urata, Y. Kawaoka, and J. Yasuda. 2009. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83:2382-2385.
38. Sato, K., M. Sato, and A. Nakano. 2003. Rer1p, a retrieval receptor for ER membrane proteins, recognizes transmembrane domains in multiple modes. Mol. Biol. Cell 14:3605-3616.
39. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
40. Simon, I. D., J. Publicover, and J. K. Rose. 2007. Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA. J. Virol. 81:2078-2082.
41. Stojdl, D. F., N. Abraham, S. Knowles, R. Marius, A. Brasey, B. D. Lichty, E. G. Brown, N. Sonenberg, and J. C. Bell. 2000. The murine doublestranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
42. Takeuchi, O., and S. Akira. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20:17-22.
43. Tanaka, S. S., Y. L. Yamaguchi, B. Tsoi, H. Lickert, and P. P. Tam. 2005. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev. Cell 9:745-756.
44. Trottier, M. D., Jr., B. M. Palian, and C. S. Reiss. 2005. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333:215-225.
45. Whitaker-Dowling, P. A., D. K. Wilcox, C. C. Widnell, and J. S. Youngner. 1983. Interferon-mediated inhibition of virus penetration. Proc. Natl. Acad. Sci. U. S. A. 80:1083-1086.
46. Xu, Y., G. Yang, and G. Hu. 2009. Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation. Acta Biochim. Biophys. Sin. (Shanghai) 41:488-494.
47. Yang, G., Y. Xu, X. Chen, and G. Hu. 2007. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 26:594-603. (Pubitemid 46160972)
48. Yang, Y., J. H. Lee, K. Y. Kim, H. K. Song, J. K. Kim, S. R. Yoon, D. Cho, K. S. Song, Y. H. Lee, and I. Choi. 2005. The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett. 221:191-200. (Pubitemid 40460406)
49. Zhang, Y., C. W. Burke, K. D. Ryman, and W. B. Klimstra. 2007. Identifi- cation and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81:11246-11255.
50. Zhou, A., J. M. Paranjape, S. D. Der, B. R. Williams, and R. H. Silverman. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440.